import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰å…¨æ™¯åœ– (2026 å°ˆå®¶å¯¦è­‰çµ‚æ¥µæ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === æ¥µè‡´ç·Šç·»åŒ– UI èˆ‡ é«˜å°æ¯”åº¦æ–‡å­— === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 30px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé›¶ç•™ç™½è¨­è¨ˆï¼Œé«˜åº¦éš¨å…§å®¹æ’é–‹ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent; background: white; 
        margin-bottom: 4px; overflow: hidden; height: auto !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center;
    }

    /* å­å€å¡Š (SoC èˆ‡åˆ†å­äºå‹) */
    .sub-block {
        margin: 2px 4px; padding: 4px;
        border-radius: 6px; background: #F8F9FA;
        border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 13px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
    }

    /* éšæ®µé…è‰² */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²å­—é«” (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 12px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="Eli Lilly"] { background: #FCE4EC !important; border-left: 5px solid #E91E63 !important; } 
    .stPopover button[aria-label*="Daiichi Sankyo"] { background: #E8F5E9 !important; border-left: 5px solid #4CAF50 !important; } 
    .stPopover button[aria-label*="MSD"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; } 
    .stPopover button[aria-label*="AstraZeneca"] { background: #F3E5F5 !important; border-left: 5px solid #8E24AA !important; } 
    .stPopover button[aria-label*="GSK"] { background: #FFF3E0 !important; border-left: 5px solid #F57C00 !important; } 
    .stPopover button[aria-label*="Gilead"] { background: #E1F5FE !important; border-left: 5px solid #03A9F4 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 48px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªæ¶æ§‹ï¼šPSOC/PROC åˆ†æµèˆ‡å…¨ç™Œç—‡å›æ­¸ ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "MMRd / MSI-H", "content": "ä¸€ç·šé¦–é¸ï¼šChemo + PD-1 (GY018/RUBY)ã€‚"},
            {"title": "NSMP / pMMR", "content": "è¦– ER/Grade åŠ æ¬Šã€‚"},
            {"title": "POLEmut / p53abn", "content": "POLE: æœ€ä½³é å¾Œï¼›p53: æœ€å·®é å¾Œéœ€ç©æ¥µåŒ–æ”¾ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "å»¶çºŒä¸€ç·šä½¿ç”¨çš„å…ç–«è—¥ç‰©ç¶­æŒè‡³é€²å±•ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "æ¨™æº–äºŒç·šï¼šPembro + Lenva (pMMR) æˆ–å–®è—¥ IO (MMRd)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒç•¶å‰æœ‰æ•ˆæ²»ç™‚ç›´åˆ°é€²å±•ã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "Surgery + Carbo/Pacli Â± Bevacizumabã€‚"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "åˆ¤å®šï¼šCK7+/SATB2-ã€‚1. Expansile: é å¾Œä½³ï¼ŒIAæœŸå¯ä¿å®ˆã€‚ 2. Infiltrative: é«˜é¢¨éšªå»ºå»ºè­°ç©æ¥µåŒ–ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥ç¶­æŒã€‚"}, {"title": "HRD positive (wt)", "content": "Olaparib+Bev æˆ– Niraparibã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (R-TX)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive)", "content": "PFI > 6mã€‚å«é‰‘è¤‡æ–¹åŒ–ç™‚ Â± Bevã€‚ç¬¦åˆ AGO Score è©•ä¼°äºŒæ¬¡æ‰‹è¡“ç²ç›Šã€‚"},
            {"title": "PROC (Resistant)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ– FRÎ± ADC (Elahere)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive Maint", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Early Stage", "content": "å‚³çµ±é–‹è…¹æ ¹æ²»è¡“ï¼›ä½é¢¨éšªé¸å–®ç´”åˆ‡é™¤ã€‚"},
            {"title": "Locally Advanced (CCRT)", "content": "CCRT Â± åŒæ­¥ IO (A18) æˆ–èª˜å°åŒ–ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic Maint", "content": "1L IO ç¶­æŒç›´è‡³é€²å±•ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "1L Recurrent", "content": "Pembro + åŒ–ç™‚ Â± Bev (CPSâ‰¥1)ã€‚"},
            {"title": "2L / 3L Therapy", "content": "Tisotumab vedotin (Tivdak) æˆ– Cemiplimabã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ°é€²å±•ã€‚"}]}
    ]
}

# --- 2. å¯¦è­‰é‡Œç¨‹ç¢‘è³‡æ–™åº« (ğŸ“š Milestone - æ·±åº¦æ“´å……ç”Ÿå­˜æ•¸æ“š) ---
milestone_db = [
    # Endometrial
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H"], "name": "ğŸ“š RUBY (Dostarlimab)", "drug": "Dostarlimab + CP", 
     "summary": "æ—ç¾¤ï¼šæ™šæœŸæˆ–å¾©ç™¼ EC (å« Carcinosarcoma/Serous)ã€‚çµæœï¼šdMMR æ­»äº¡é¢¨éšªé™ä½ 68% (HR 0.32)ï¼›å…¨äººç¾¤ mOS é¡¯è‘—å»¶é•·è‡³ 44.6m (vs 28.2m, HR 0.69)ã€‚"},
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H", "NSMP / pMMR"], "name": "ğŸ“š NRG-GY018 (Pembro)", "drug": "Pembrolizumab + CP", 
     "summary": "æ—ç¾¤ï¼šIII-IVB/å¾©ç™¼ ECã€‚çµæœï¼šdMMR PFS HR 0.30ï¼›pMMR é¡¯è‘—æ”¹å–„ (HR 0.54)ã€‚FDA æ–¼ 2024 å¹´å…¨é¢æ ¸å‡†é©æ‡‰ç—‡ã€‚"},
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["NSMP / pMMR"], "name": "ğŸ“š DUO-E", "drug": "Durvalumab Â± Olaparib", 
     "summary": "çµæœï¼šDurva+Ola ä¸‰è—¥çµ„ PFS HR 0.57ï¼›å–®è—¥ IO çµ„ HR 0.77ã€‚æç¤º PARPi åœ¨ pMMR ä¸€ç·šç¶­æŒä¹‹æ½›åŠ›ã€‚"},
    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["NSMP / pMMR"], "name": "ğŸ“š KEYNOTE-775", "drug": "Pembro + Lenvatinib", 
     "summary": "äºŒç·šæ¨™ç«¿ï¼š5å¹´è¿½è¹¤ pMMR OS ç²ç›ŠæŒä¹… (16.7% vs 7.3%, HR 0.62)ã€‚ç¢ºç«‹äºŒç·šæ¨™æº–æ–¹æ¡ˆã€‚"},

    # Cervical
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š KEYNOTE-A18", "drug": "Pembrolizumab + CCRT", 
     "summary": "æ—ç¾¤ï¼šIB2-IVA é«˜é¢¨éšª LACCã€‚çµæœï¼š36å€‹æœˆç¸½é«”å­˜æ´»ç‡æå‡è‡³ 82.6% (HR 0.67)ã€‚ç¢ºç«‹åŒæ­¥å…ç–«æ¨™æº–ã€‚"},
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š INTERLACE", "drug": "Induction Chemo", 
     "summary": "èª˜å°åŒ–ç™‚ï¼š6é€± Carbo/Pacli æ¥ CCRTã€‚5å¹´ OS æ”¹å–„ (80% vs 72%, HR 0.60)ã€‚è€è—¥æ–°ç”¨åƒ¹å€¼ã€‚"},
    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["1L Recurrent"], "name": "ğŸ“š KEYNOTE-826", "drug": "Pembro + Chemo Â± Bev", 
     "summary": "R/M ä¸€ç·šã€‚å…¨äººç¾¤ OS HR 0.63ï¼›CPSâ‰¥1 æ—ç¾¤ OS é¡¯è‘—è·ç›Šï¼Œç¢ºç«‹ä¸€ç·š IO åŸºç¤åœ°ä½ã€‚"},
    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"], "name": "ğŸ“š innovaTV 301", "drug": "Tivdak (ADC)", 
     "summary": "äºŒ/ä¸‰ç·š ADCã€‚OS 11.5m vs 9.5m (HR 0.70)ï¼ŒORR 17.8%ã€‚æä¾›å¾Œç·šç”Ÿå­˜ç²ç›Šæ¨™æº–ã€‚"},
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage"], "name": "ğŸ“š LACC Trial", "drug": "Open vs MIS", 
     "summary": "éœ‡æ’¼æ€§ç™¼ç¾ï¼šå¾®å‰µæ‰‹è¡“å¾©ç™¼èˆ‡æ­»äº¡ç‡é¡¯è‘—è¼ƒé«˜ (HR 6.00)ã€‚é‡å›é–‹è…¹æ ¹æ²»è¡“æ¨™æº–ã€‚"},

    # Ovarian
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated"], "name": "ğŸ“š SOLO-1 (Olaparib)", "drug": "Olaparib", 
     "summary": "ä¸€ç·šç¶­æŒé‡Œç¨‹ç¢‘ï¼š7å¹´ survival 67% (vs 46.5%, HR 0.33)ã€‚ç¢ºç«‹ BRCAm å…·æ²»ç™’æ½›åŠ›ã€‚"},
    {"cancer": "Ovarian", "pos": "R-TX (PROC)", "sub_pos": ["PROC (PFI < 6m)"], "name": "ğŸ“š MIRASOL (FRÎ± ADC)", "drug": "Mirvetuximab", 
     "summary": "FRÎ±+ PROCã€‚OS 16.4m vs 12.7m (HR 0.67)ï¼ŒORR 42.3%ã€‚PROC æ­·å²çªç ´ã€‚"},
    {"cancer": "Ovarian", "pos": "R-TX (PSOC)", "sub_pos": ["PSOC (PFI > 6m)"], "name": "ğŸ“š DESKTOP III", "drug": "Secondary Surgery", 
     "summary": "ç¬¦åˆæ¢ä»¶ä¹‹ PSOC æ‚£è€…é€²è¡ŒäºŒæ¬¡æ‰‹è¡“é¡¯è‘—å»¶é•· OS è‡³ 53.7m (vs 46.0m)ã€‚"}
]

# --- 3. æ‹›å‹Ÿä¸­è©¦é©— (ğŸ“ Ongoing - 8 æ ¸å¿ƒè©³ç›¡ç´°ç¯€) ---
ongoing_trials = [
    {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bev", "pos": "R-TX (PROC)", "sub_pos": ["PROC (PFI < 6m)"], 
     "rationale": "æ¨™é¶ Folate Receptor alpha (FRÎ±) ADCã€‚æ­è¼‰é¡å¾®ç®¡è›‹ç™½ Payloadã€‚è¯ç”¨ Bevacizumab ç”¢ç”Ÿè¡€ç®¡èª¿ç¯€å”åŒä½œç”¨ (Synergy)ï¼Œæå‡è—¥ç‰©åœ¨è…«ç˜¤é–“è³ªçš„æ»²é€ï¼Œæ®ºå‚·ç•°è³ªæ€§è…«ç˜¤ã€‚",
     "dosing": {"Exp Arm": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚", "Control Arm": "é†«å¸«é¸æ“‡å–®è—¥åŒ–ç™‚ (Pacli, PLD, Gem) æˆ– MIRVã€‚"},
     "inclusion": ["High-grade Serous / Carcinosarcoma ä¹‹åµå·¢ç™Œã€‚", "ä¸­å¤®å¯¦é©—å®¤æª¢æ¸¬ç¢ºèª FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©å…§æƒ¡åŒ– (PROC)ã€‚", "å…ˆå‰æ¥å—é 1â€“3 ç·šç³»çµ±æ²»ç™‚ã€‚"],
     "exclusion": ["å…ˆå‰æ›¾ç”¨éå¸¶æœ‰ Topoisomerase I æŠ‘åˆ¶åŠ‘ Payload ä¹‹ ADC (å¦‚ Enhertu)ã€‚", "å…·æœ‰è‡¨åºŠé¡¯è‘—è›‹ç™½å°¿ (UPCR â‰¥ 2.0)ã€‚", "æ´»å‹•æ€§ ILD ç—…å²ã€‚"], "ref": "NCT06536348"},
    
    {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX (PROC)", "sub_pos": ["PROC (PFI < 6m)"], 
     "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCï¼Œæ­è¼‰å¼·æ•ˆ DXd è¼‰è·ã€‚å…·å‚™æ¥µé«˜ DAR (8) èˆ‡å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ (Bystander effect)ï¼Œå°ˆæ”»é«˜åº¦ç•°è³ªæ€§ä¸” CDH6 è¡¨é”ä¹‹ PROCã€‚",
     "dosing": {"Exp Arm": "R-DXd 5.6mg/kg IV Q3Wã€‚", "Control Arm": "Investigator's Choice å–®è—¥åŒ–ç™‚ã€‚"},
     "inclusion": ["HG Serous æˆ– Endometrioid PROCã€‚", "å…ˆå‰æ¥å— 1-4 ç·šç³»çµ±æ²»ç™‚ã€‚", "éœ€æä¾›çµ„ç¹”æª¢é«”é€²è¡Œ CDH6 åˆ†å±¤ã€‚", "éœ€æ›¾ç”¨é Bevacizumabã€‚"],
     "exclusion": ["Low-grade / Clear cell / Mucinous (åŸç™¼)ã€‚", "LVEF < 50% æˆ–åŸºç·š Grade â‰¥2 å‘¨é‚Šç¥ç¶“ç—…è®Šã€‚"], "ref": "JCO 2024"},
    
    {"cancer": "Ovarian", "name": "TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD negative / pHRD"], 
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°çš„ ICD æ•ˆæ‡‰ï¼Œæ—¨åœ¨å„ªåŒ– pHRD æ—ç¾¤åœ¨ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œç¶­æŒæ™‚çš„ç²ç›Šï¼ŒæŒ‘æˆ°ç¾æœ‰ SoCã€‚",
     "inclusion": ["æ–°è¨ºæ–· FIGO III/IV åµå·¢ç™Œã€‚", "HRD negative ä¸” BRCA é‡ç”Ÿå‹ã€‚", "ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œé” CR æˆ– PR ç‹€æ…‹ã€‚", "å¯ä¾›æª¢æ¸¬ Trop-2 è¡¨é”ä¹‹æª¢é«”ã€‚"],
     "exclusion": ["BRCA çªè®Šã€‚", "å…ˆå‰ç”¨é Trop-2 ADCã€‚", "åš´é‡ç‚ç—‡æ€§è…¸é“ç–¾ç—… (IBD) ç—…å²ã€‚"], "ref": "ENGOT-ov85"},

    {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": ["IO Maintenance"], 
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1 æŠ‘åˆ¶åŠ‘ã€‚é€éå…ç–«èª¿ç¯€å¼·åŒ– Pembrolizumab åœ¨ pMMR æˆ– NSMP æ—ç¾¤çš„é•·æœŸæ‡‰ç­”æ·±åº¦èˆ‡æ‡‰ç­”ç‡ã€‚",
     "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚", "åˆæ¬¡å¾©ç™¼ä¸”æœªé‡å°å¾©ç™¼æ²»ç™‚ã€‚"],
     "exclusion": ["å­å®®è‚‰ç˜¤ (Sarcoma)ã€‚", "å…ˆå‰æ¥å—éæ™šæœŸç³»çµ±æ€§ IO æ²»ç™‚ã€‚"], "ref": "ESMO 2025"},
    
    {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["Recurrent EC"], 
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚åˆ©ç”¨ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«å¤±æ•—æ•‘æ´ï¼Œå…·å‚™å¼·å¤§ Bystander æ•ˆæ‡‰è§£æ±ºç•°è³ªæ€§å•é¡Œã€‚",
     "inclusion": ["å¾©ç™¼æ€§ EC (ä¸å«è‚‰ç˜¤)ã€‚", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•ã€‚", "å……åˆ†å™¨å®˜åŠŸèƒ½ (ANC â‰¥1500)ã€‚"],
     "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADCã€‚", "æ´»å‹•æ€§ CNS è½‰ç§»ã€‚"], "ref": "JCO 2024"},

    {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], 
     "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç¶­æŒé¦–é¸ã€‚è¶…é«˜ DAR (8) å„ªå‹¢æ¸…é™¤ HER2 è¡¨ç¾æ®˜ç•™ç—…ç¶ï¼Œå»¶é•·ç·©è§£æ™‚é–“ã€‚",
     "inclusion": ["HER2 IHC 1+/2+/3+ ç¢ºèªã€‚", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)ã€‚", "LVEF â‰¥ 50%ã€‚"],
     "exclusion": ["æ›¾æ‚£æœ‰éœ€é¡å›ºé†‡æ²»ç™‚ä¹‹éæ„ŸæŸ“æ€§ ILD è‚ºéƒ¨ç—…å²ã€‚"], "ref": "JCO 2024"},

    {"cancer": "Ovarian", "name": "DOVE", "pharma": "GSK", "drug": "Dostarlimab + Bev", "pos": "R-TX (PROC)", "sub_pos": ["PROC (PFI < 6m)"], 
     "rationale": "é‡å°é€æ˜ç´°èƒç™Œ (OCCC)ã€‚PD-1 + VEGF é›™é‡é˜»æ–·æ”¹å–„å…ç–«æŠ‘åˆ¶ç’°å¢ƒï¼Œèª˜ç™¼é•·æœŸæŒçºŒæ‡‰ç­”ã€‚",
     "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%ã€‚", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)ã€‚", "å…ˆå‰ç·šæ•¸ â‰¤ 5ã€‚"],
     "exclusion": ["å…ˆå‰ç”¨éä»»ä½•å…ç–«æ²»ç™‚ã€‚"], "ref": "JCO 2025"},

    {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"], 
     "rationale": "æ¨™é¶ Tissue Factor (TF) ADCã€‚æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ï¼Œæä¾›ç”Ÿå­˜ç²ç›Š OSã€‚",
     "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œã€‚", "å…ˆå‰æ¥å— 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•ã€‚"],
     "exclusion": ["åš´é‡çœ¼ç–¾æˆ–è§’è†œç‚ã€‚", "æ´»å‹•æ€§å‡ºè¡€å‚¾å‘ã€‚"], "ref": "NEJM 2024"}
]

# --- 4. å‹•æ…‹æ¨¡å‹å·¡é‚èˆ‡ AI æ¨¡å‹é¸æ“‡ ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = None
        for m in available_models:
            if 'gemini-1.5-flash' in m: target_model = m; break
        if not target_model:
            for m in available_models:
                if 'gemini-pro' in m or 'gemini-1.5-pro' in m: target_model = m; break
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 5. å´é‚Šæ¬„ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = ongoing_trials[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰æ±ºç­–åŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ ç—…æ­·æ·±åº¦æ•¸æ“šæ¯”å°", expanded=True):
        p_notes = st.text_area("è¼¸å…¥æ‘˜è¦ (å«æœŸåˆ¥/æ¨™è¨˜)", height=250)
        if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    if model:
                        prompt = f"åˆ†æï¼š{p_notes}ã€‚åƒè€ƒé‡Œç¨‹ç¢‘å¯¦è­‰ï¼š{milestone_db} åŠæ‹›å‹Ÿä¸­è©¦é©—ï¼š{ongoing_trials}ã€‚æä¾›æœ€ä½³è·¯å¾‘èˆ‡ç†ç”±ã€‚"
                        st.write(model.generate_content(prompt).text)
                    else: st.error("æ‰¾ä¸åˆ°å¯ç”¨ AI æ¨¡å‹ã€‚")
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 6. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 å¯¦è­‰èˆ‡æ”¶æ¡ˆå…¨æ•´åˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

st.subheader("ç¬¬äºŒæ­¥ï¼šé»æ“Š ğŸ“š å¯¦è­‰é‡Œç¨‹ç¢‘ æˆ– ğŸ“ æ‹›å‹Ÿä¸­è©¦é©— (èˆ‡ SoC åŒæ­¥å°ç…§)")
cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # A. å¯¦è­‰é‡Œç¨‹ç¢‘ (ğŸ“š)
            rel_milestones = [m for m in milestone_db if m["cancer"] == cancer_type and m["pos"] == stage["id"] and any(s in sub["title"] for s in m["sub_pos"])]
            for m in rel_milestones:
                with st.popover(f"ğŸ“š {m['name']}", use_container_width=True):
                    st.success(f"**ä»‹å…¥:** {m['drug']}\n\n**è©³ç´°æ•¸æ“š:** {m['summary']}")
            
            # B. æ‹›å‹Ÿä¸­è©¦é©— (ğŸ“)
            rel_trials = [t for t in ongoing_trials if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"ğŸ“ {t['pharma']} | {t['name']}"
                ukey = f"btn_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
                with st.popover(label, use_container_width=True):
                    if st.button("ğŸ“Š è©³ç´°ç´°ç¯€å ±å‘Š", key=ukey):
                        st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 7. æ‹›å‹Ÿä¸­è©¦é©—æ¥µé‡åŒ–å ±å‘Š ---
st.divider()
t_options = [t["name"] for t in ongoing_trials if t["cancer"] == cancer_type]
if t_options:
    try: curr_idx = t_options.index(st.session_state.selected_trial)
    except: curr_idx = 0
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›æ‹›å‹Ÿä¸­è©¦é©—ä¹‹æ·±åº¦åˆ†æï¼š", t_options, index=curr_idx)
    t = next(it for it in ongoing_trials if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ‹›å‹Ÿä¸­æ¥µé‡åŒ–æ·±åº¦å ±å‘Š</h2>", unsafe_allow_html=True)

    r1, r2 = st.columns([1.3, 1])
    with r1:
        st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Protocol (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        st.success(t['rationale'])
        

    with r2:
        st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥é–€æª»)</b></div>", unsafe_allow_html=True)
        for inc in t.get('inclusion', []): st.write(f"â€¢ **{inc}**")

    st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px; margin-top:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for exc in t.get('exclusion', []): st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
